Manufacturers Life Insurance Company, The Xeris Biopharma Holdings, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 56,143 shares of XERS stock, worth $163,937. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,143
Previous 57,805
2.88%
Holding current value
$163,937
Previous $130,000
23.08%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding XERS
# of Institutions
141Shares Held
59.9MCall Options Held
148KPut Options Held
45.7K-
Black Rock Inc. New York, NY10.3MShares$30.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.77MShares$22.7 Million0.0% of portfolio
-
Caxton Corp Princeton, NJ5.11MShares$14.9 Million62.59% of portfolio
-
Center Book Partners LP Greenwich, CT3.48MShares$10.2 Million0.64% of portfolio
-
Geode Capital Management, LLC Boston, MA3.33MShares$9.73 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $397M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...